Clinical Trial: A Phase 2 Study of Allogeneic Stem Cell Transplant in Myelodysplastic Syndrome Following Conditioning With Fludarabine and Total Body Irradiation 800 cGy

U.S., Oct. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07896928) titled 'A Phase 2 Study of Allogeneic Stem Cell Transplant in Myelodysplastic Syndrome Following Conditioning With Fludarabine and Total Body Irradiation 800 cGy' on Oct. 20.

Brief Summary: This is a single center phase II study of allogeneic stem cell transplantation in MDS who are unlikely to benefit from conventional therapy. Patients will undergo standard allogeneic stem cell transplant protocol following standard Flu/TBI 800 conditioning, PBSC transplant, and GVHD prophylaxis with PTCy and tacrolimus.

Study Start Date: Dec., 2026

Study Type: INTERVENTIONAL

Condition: MDS Myelodysplastic Syndrome MDS Myelodysplastic Syndrome (MDS) M...